Replies to post #226087 on Biotech Values

[DewDiligence]

OPGN +110% on COVID-19 PR from CURE.AS—the company OPGN is reverse-merging with:

https://finance.yahoo.com/news/curetis-begins-offering-bgi-ce-070158290.html

CURE.AS itself is +82% as I’m typing. The companies agreed to merge in Sep 2019 (#msg-150924660), but the OPGN shareholder vote to approve the merger was postponed to 3/30/20 because the meeting held on 3/10/20 did not produce a quorum.

[DewDiligence]

OPGN closes reverse-merger with CURE.AS:

https://www.globenewswire.com/news-release/2020/04/01/2010279/0/en/Curetis-and-OpGen-Close-Business-Combination.html